Ellipse Technologies

About:

Ellipse Technologies develops implantable technologies for the treatment of a broad spectrum of spine and orthopedic applications.

Website: http://www.ellipse-tech.com

Twitter/X: goellipse

Top Investors: Wexford Capital, HBM Healthcare Investments, BioStar Capital, MedFocus Fund

Description:

Ellipse Technologies is focused on developing its implantable remote control technology platforms to include innovative treatments for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management. The initial products restore proper anatomic position and alignment of the spine and long-bones. MAGECâ„¢ MAGnetic Expansion Control System utilizes a novel motion-preserving, minimally-invasive technology that, through communication with an external magnetic field, can be non-invasively adjusted in an outpatient setting via remote control by the physician to correct spinal deformities. PRECICE System uses non-invasive adjustable intramedullary rods or bone plates to treat long-bone abnormalities, often the result of acute or chronic fractures. Ellipse is a privately-held medical device company located in California.

Total Funding Amount:

$38.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Aliso Viejo, California, United States

Founded Date:

2005-01-01

Contact Email:

cs(AT)ellipse-tech.com

Founders:

Samuel Shaolian, Shawn Moaddeb

Number of Employees:

51-100

Last Funding Date:

2015-06-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai